Zelira in the news
PAEDIATRIC BRAIN CANCER RESEARCH UPDATE
Zelda Therapeutics Ltd (ASX: ZLD, US OTC: ZLDAF, Zelda or the Company) is pleased to provide an update on its previously announced paediatric brain cancer research project with the prestigious Telethon Kids Institute (“TKI” or “the Institute) in Perth, Western Australia.